The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Posuwan, Nawarat ^a   Wanlapakorn, Nasamon ^a   Sa Nguanmoo, Pattaratida ^a   Wasitthankasem, Rujipat ^a   Vichaiwattana, Preeyaporn ^a   Klinfueng, Sirapa ^a   Vuthitanachot, Viboonsak ^b   Sae Lao, Siriporn ^b   Foonoi, Monthana ^c   Fakthongyoo, Apinya ^c   Makaroon, Jamorn ^d   Srisingh, Klaita ^e   Asawarachun, Duangporn ^f   Owatanapanich, Somchai ^g   Wutthiratkowit, Norra ^h   Tohtubtiang, Kraisorn ⁱ   Yoocharoen, Pornsak ^j   Vongpunsawad, Sompong ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Chumphae Hospital   (Thailand)

^c Uttaradit Hospital   (Thailand)

^d Laboratory Medicine   (Thailand)

^e NARESUAN UNIVERSITY   (Thailand)

^f Phra Nakhon Si Ayutthaya Hospital   (Thailand)

^g King Narai Hospital   (Thailand)

^h Narathiwat Ratchanakarin Hospital   (Thailand)

ⁱ Trang Hospital   (Thailand)

^j MINISTRY OF PUBLIC HEALTH   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GEOGRAPHY; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MALE; NEWBORN; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; THAILAND; VIRUS CARRIER; HEPATITIS B VIRUS; IMMUNOLOGY; INFANT; MIDDLE AGED; PATHOGENICITY; VIROLOGY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; INFANT; MIDDLE AGED; THAILAND;

EID: 84961275931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150499     Document Type: Article

References (27)

1. WHO. Department of Communicable Diseases Surveillance and Response. Hepatitis B. 2002. Available from: URL: Http://www.who.int/csr/disease/hepatitis/HepatitisB-whocdscsrlyo2002-2.pdf.
2. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005; 2 (1): 50-57. PMID: 15968340.
3. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: A review. Clin Infect Dis. 1995; 20(4): 992-1000. PMID: 7795104.
4. Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol. 2000; 15. PMID: 10921376.
5. Wen WH, Chang MH, Zhao LL, Ni YH, Hsu HY, Wu JF, et al. Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention. J Hepatol. 2013; 59 (1): 24-30.doi: 10.1016/j.jhep.2013.02.015 PMID: 23485519.
6. Cheng A, Jose J, Larsen-Reindorf R, Small C, Nde H, Dugas L, et al. A Survey Study of Pregnant Women and Healthcare Practitioners Assessing the Knowledge of Attitudes and Practices of Hepatitis B Management at a Teaching Hospital in Kumasi, Ghana, West Africa. Open Forum Infect Dis. 2015; 2 (4): Ofv122.doi: 10.1093/ofid/ofv122 PMID: 26566533.
7. Poovorawan Y, Theamboonlers A, Vimolket T, Sinlaparatsamee S, Chaiear K, Siraprapasiri T, et al. Impact of hepatitis B immunisation as part of the EPI. Vaccine. 2000; 19(7-8): 943-949. PMID: 11115720.
8. Chunsuttiwat S, Biggs BA, Maynard JE, Thammapormpilas P, O-Prasertsawat M. Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand. Vaccine. 2002; 21(3-4): 188-193. PMID: 12450693.
9. Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine. 2009; 27(44): 6110-6115.doi: 10.1016/j.vaccine.2009.08.034 PMID: 19716459.
10. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000; 18 Suppl 1: S20-2. PMID: 10683538.
11. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand. Hum Vaccin Immunother. 2013; 9(8): 1679-1684.doi: 10.4161/hv.24844 PMID: 23732904
12. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health. 2006; 11(10): 1496-1502. PMID: 17002723.
13. Chimparlee N, Oota S, Phikulsod S, Tangkijvanich P, Poovorawan Y. Hepatitis B and hepatitis C virus in Thai blood donors. Southeast Asian J Trop Med Public Health. 2011; 42(3): 609-615. PMID: 21706939.
14. Theamboonlers A, Chongsrisawat V, Jantaradsamee P, Poovorawan Y. Variants within the "a" determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of Thailand's Expanded Program on Immunization (EPI). Tohoku J Exp Med. 2001; 193(3): 197-205. PMID: 11315767.
15. Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Thawornsuk N, et al. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: A case-control study in Thailand. J Med Virol. 2012; 84(8): 1177-1185.doi: 10.1002/jmv. 23260 PMID: 22711345.
16. Yimnoi P, Posuwan N, Wanlapakorn N, Tangkijvanich P, Theamboonlers A, Vongpunsawad S, et al. A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization. J Med Virol. 2015.doi: 10.1002/jmv.24368 PMID: 26331587.
17. Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, et al. Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014; 133(6): E1500-1507.doi: 10.1542/peds.2013-2940 PMID: 24843060.
18. Wang CW, Wang LC, Chang MH, Ni YH, Chen HL, Hsu HY, et al. Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: Correlation between radioimmunoassay and enzyme immunoassay. Clin Diagn Lab Immunol. 2005; 12(12): 1442-1447. PMID: 16339069.
19. Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology. 1999; 29(3): 954-959. PMID: 10051503.
20. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Srinivasa K, Hutagalung Y, Bock HL, et al. Longterm benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. J Infect Dis. 2009; 200(1): 33-38.doi: 10.1086/599331 PMID: 19473096.
21. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine. 2010; 28(3): 730-736. PMID: 19892043.
22. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat. 2011; 18(5): 369-375.doi: 10.1111/j.1365-2893.2010. 01312.x PMID: 20384962.
23. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Crasta PD, Hardt K. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers. Hum Vaccin Immunother. 2012; 8(7): 896-904.doi: 10.4161/hv. 19989 PMID: 22777097.
24. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand. Hum Vaccin Immunother. 2013; 9(8): 1679-1684.doi: 10.4161/hv.24844 PMID: 23732904.
25. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet. 2000; 355(9203): 561-565. PMID: 10683019.
26. Ni YH, Chen DS. Hepatitis B vaccination in children: The Taiwan experience. Pathol Biol (Paris). 2010; 58(4): 296-300.doi: 10.1016/j.patbio.2009.11.002 PMID: 20116181.
27. Qu C, Chen T, Fan C, Zhan Q, Wang Y, Lu J, et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: A cluster randomized controlled trial. PLoS Med. 2014; 11(12): E1001774.doi: 10.1371/journal.pmed.1001774 PMID: 25549238